Octagam (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a 10% solution for intravenous use. It treats primary immunodeficiency disorders and provides immune support in patients with secondary immunodeficiency conditions. GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Octagam is an immunoglobulin used to replace deficient antibodies and modify immune responses in several clinical settings.

- Primary immunodeficiency diseases: restores normal immunoglobulin levels and reduces infection frequency. - Secondary immunodeficiency (e.g., chronic lymphocytic leukemia, HIV infection): provides passive immunity to lower infection risk. - Hematopoietic stem cell transplantation (HSCT) conditioning: helps prevent graft‑versus‑host disease and infection complications. - Immune thrombocytopenic purpura (ITP) refractory to steroids: raises platelet counts by modulating auto‑antibody activity. - Kawasaki disease with coronary artery involvement: reduces inflammation and aneurysm formation.

Adverse reactions to Octagam are generally related to infusion and immune modulation.

Common Side Effects: - Headache - Mild fever - Chills or rigors - Nausea - Fatigue - Injection site erythema

Serious or Rare Side Effects: - Anaphylaxis or severe hypersensitivity - Acute hemolytic anemia - Renal impairment or acute kidney injury - Thromboembolic events - Aseptic meningitis - Severe thrombocytopenia

Octagam should be administered under medical supervision with attention to patient‑specific risk factors.

- Assess renal function: adjust infusion rate in patients with renal impairment. - Screen for IgA deficiency: patients with anti‑IgA antibodies may develop severe reactions. - Monitor for thrombotic risk: consider prophylaxis in patients with known hypercoagulability. - Evaluate cardiac status: rapid infusions can cause fluid overload in heart‑failure patients. - Observe for signs of infection: immunoglobulin does not treat active infections. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Octagam may interact with other agents that affect immune function or renal clearance.

Major Interactions (Avoid): - Live vaccines: concurrent use can diminish vaccine efficacy and increase adverse events. - High‑dose aspirin or other NSAIDs: may increase risk of renal dysfunction when combined with immunoglobulin.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate fluid shifts during infusion. - Anticoagulants (e.g., warfarin): monitor coagulation parameters as immunoglobulin can affect clotting factors. - ACE inhibitors: watch for additive renal effects. - Rituximab or other B‑cell depleting agents: may alter therapeutic response. - Corticines (corticost ).